The share allotment status for the Corona Remedies IPO is scheduled to be finalised on December 11.

On the final day of bidding on Wednesday, the initial public offering (IPO) of the pharmaceutical company was overall booked 137.04 times. The ₹655.37-crore mainboard IPO received bids for 62.65 crore shares against 45.72 lakh shares on offer.

The retail quota of the Corona Remedies IPO was booked 28.73 times. The Qualified Institutional Buyers (QIBs) subscribed their segment 278.52 times. The Non-Institutional Investors (NIIs) booked the issue 208.88 times.

The IPO was open for subscription from December 8 to December 10. The mainboard issue comprised only an offer-for-sale (OFS) portion of 61.71 lakh shares. The price band for the IPO was set between ₹1,008 and ₹1,062 per share.

Invest

See Full Page